www.FedPrimeRate.com - The United States Prime Rate Website

Asbestos Cancer

The Latest News, Trends, Updates and Information About Mesothelioma & Asbestos Cancer.

Friday, November 18, 2005

Alimta Gets The Fast Track in Japan

Japan's Ministry of Health, Labor and Welfare has decided to reduce the review period for the mesothelioma drug Alimta (also known as Pemetrexed) to one year. In Japan, the review process for new drugs usually takes about 2 years.

This priority review decision by the Japanese authorities comes as no surprise, as an alarming percentage of Japanese citizens have developed asbestos cancer as a result of asbestos exposure in the workplace.

The Japanese government didn't ban the two most dangerous forms of asbestos until 1995.

--> www.FedPrimeRate.com Privacy Policy <--

>  SITEMAP  <

Retired Sheet Metal Worker Is Awarded $1,900,000 In A Mesothelioma Case Involving Chrysotile (White Asbestos)

Amosite (or brown asbestos) and crocidolite (or blue asbestos) are the most dangerous forms of asbestos, so when you read about a court case involving asbestos cancer or mesothelioma, amosite or crocidolite are usually at the heart of the case.

Chrysotile (or white asbestos) is not usually implicated in mesothelioma cases, as it is considered to be a benign form of asbestos, but it can sometimes be dangerous, especially when it is broken up into tiny fragments and allowed to become airborne, as is often the case when chrysotile is used in industry.

Chrysotile was at the heart of a recent case involving Genaro Garcia, a 71-year-old retired sheet metal worker who developed peritoneal mesothelioma as a result of long term exposure to chrysotile. Details can be found below, in a snippet from a press release that was issued today:

"A jury awarded over $1.9 million to a 71–year–old retired sheet metal worker, Genaro Garcia, who developed peritoneal mesothelioma from his prior on–the–job exposure to asbestos (Genaro Garcia and Dalia Garcia v. Duro Dyne Corporation, SF Superior Court, #418098). Peritoneal mesothelioma is an aggressive form of cancer that first attacks the membranes lining the stomach. This fatal disease is almost always caused by asbestos exposure.

The defendant, Duro Dyne Corporation, is a former manufacturer and distributor of asbestos–containing flex HVAC duct connectors and duct sealer used for sheet metal duct connections. Mr. Garcia worked with Duro Dyne Corporation's asbestos–containing sheet metal products throughout his 48–year career, but was never advised to wear any form of respiratory protection. Experts testified that he was exposed to hazardous levels of asbestos, and that each exposure was a substantial factor that contributed to his risk of developing an asbestos–related disease.

Mr. Garcia learned that he had peritoneal mesothelioma in late 2002. After over two years of treatment with chemotherapy, including Alimta®, his cancer is currently in a temporary state of remission. Mr. Garcia traveled with his wife by car from Whittier, California, to testify at the San Francisco trial. He was unable to travel by plane due to the severe side effects of his chemotherapy regime.

The verdict against Duro Dyne Corporation consisted of $325,369 for past and future medical expenses, $530,250 for lost earning capacity, and $1.05 million in non-economic damages. Non-economic damages included $300,000 to Mrs. Garcia for loss of consortium.

'We are grateful that the jury rejected the defense claims that chrysotile asbestos does not cause all mesothelioma, including peritoneal, and that Mr. Garcia is somehow cured of this terrible and entirely preventable disease. Only in a courtroom would you hear such things,' said Mr. Garcia’s attorney, Gilbert Purcell, after the verdict.

Gilbert Purcell and Crystal Howard of Brayton Purcell in Novato, California, represented plaintiffs Genaro and Delia Garcia at trial. Duro Dyne Corporation was represented at trial by James Sinunu and Thomas Trapani of Adams Nye Sinunu Bruni Becht LLP of San Francisco, CA."

--> www.FedPrimeRate.com Privacy Policy <--

>  SITEMAP  <



Horizontal RULE

SCAM ALERT!

Horizontal RULE

bing

bing


FedPrimeRate.com
Entire Website © 2024 FedPrimeRate.comSM


This website is neither affiliated nor associated with The United States Federal Reserve
in any way. Information in this website is provided for educational purposes only.
The owners of this website make no warranties with respect to any and all content
contained within this website. Consult a financial professional before making important
decisions related to any investment or loan product, including, but not limited to,
business loans, personal loans, education loans, first or second mortgages,
credit cards, car loans or any type of insurance.